MENU
Logo

BPS Store

Grid View List View
Drug Discovery for Ion Channels XXII Satellite Meeting

Drug Discovery for Ion Channels XXII Satellite Meeting

sku Product SKU:  SMEETING-M22_DRUGDISC-2022

On-site registration WILL NOT be available.

Ion channels are an important class of therapeutic drug targets, and mutations in ion channel genes are found to be responsible for an increasing number of diseases. While conventional electrophysiological techniques permit the most detailed and direct study of ion channel function, they are limited due to the manual nature of the method and their low throughput. Because of this, ion channels remain an underrepresented target class for drug discovery. The advent of higher throughput automated electrophysiology systems changed the face of ion channel drug discovery.

This year’s meeting will highlight presentations from drug discovery companies, companies that provide ion channel services to drug discovery companies and companies that provide products to ion channel drug discovery companies, as well as other speakers in the field of ion channel drug discovery, including several academic speakers.

VACCINE REQUIREMENT: BPS will be adhering to the city of San Francisco’s requirement of proof of vaccination for large events at indoor venues. Only individuals who are fully vaccinated with a FDA-authorized vaccine or a vaccine authorized for emergency use by the World Health Organization will have access to the Moscone Center. Everyone is required to be fully vaccinated whether he or she is a presenter, attendee, exhibitor, vendor, guest, or staff member. Masks will also be required. Additional details, including instructions for the verification process will be provided at a later date.

Sponsored by:

USD 150.0000

  • Paid! View Details {{product.ModelName}}

    {{product.ModelName}}

    Select {{product.UnitCost | currency : '$' : 2}} {{product.SalePrice | currency : '$' : 2}} {{product.UnitCost | currency : '$' : 2}}